
### [MONDO:0003833](http://purl.obolibrary.org/obo/MONDO_0003833)
**Label:** severe combined immunodeficiency (disease)

**Subclasses:** [MONDO:0011086](http://purl.obolibrary.org/obo/MONDO_0011086) (severe combined immunodeficiency, autosomal recessive, T cell-negative, b cell-negative, Nk cell-positive), [MONDO:0012163](http://purl.obolibrary.org/obo/MONDO_0012163) (severe combined immunodeficiency, autosomal recessive, T cell-negative, b cell-positive, Nk cell-positive), [MONDO:0014278](http://purl.obolibrary.org/obo/MONDO_0014278) (immunodeficiency 18), [MONDO:0011132](http://purl.obolibrary.org/obo/MONDO_0011132) (T-cell immunodeficiency, congenital alopecia, and nail dystrophy), [MONDO:0014280](http://purl.obolibrary.org/obo/MONDO_0014280) (immunodeficiency 19), [MONDO:0009973](http://purl.obolibrary.org/obo/MONDO_0009973) (reticular dysgenesis), [MONDO:0009456](http://purl.obolibrary.org/obo/MONDO_0009456) (Immunoerythromyeloid hypoplasia), [MONDO:0009434](http://purl.obolibrary.org/obo/MONDO_0009434) (hypoproteinemia, Hypercatabolic), [MONDO:0008855](http://purl.obolibrary.org/obo/MONDO_0008855) (MHC class II deficiency), [MONDO:0010938](http://purl.obolibrary.org/obo/MONDO_0010938) (T-b+ severe combined immunodeficiency due to JAK3 deficiency), [MONDO:0011225](http://purl.obolibrary.org/obo/MONDO_0011225) (severe combined immunodeficiency with sensitivity to ionizing radiation), [MONDO:0007064](http://purl.obolibrary.org/obo/MONDO_0007064) (adenosine deaminase deficiency), [MONDO:0011476](http://purl.obolibrary.org/obo/MONDO_0011476) (MHC class i deficiency), [MONDO:0015701](http://purl.obolibrary.org/obo/MONDO_0015701) (T-b+ severe combined immunodeficiency due to IL-7Ralpha deficiency), [MONDO:0011338](http://purl.obolibrary.org/obo/MONDO_0011338) (Omenn syndrome), [MONDO:0015703](http://purl.obolibrary.org/obo/MONDO_0015703) (T-b+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta), [MONDO:0010315](http://purl.obolibrary.org/obo/MONDO_0010315) (gamma chain deficiency), [MONDO:0012426](http://purl.obolibrary.org/obo/MONDO_0012426) (immunodeficiency 25), [MONDO:0015702](http://purl.obolibrary.org/obo/MONDO_0015702) (T-b+ severe combined immunodeficiency due to CD45 deficiency), 

**Corr. equiv. classes:** [Orphanet:169095](http://www.orpha.net/ORDO/Orphanet_169095), [OMIM:603554](http://purl.obolibrary.org/obo/OMIM_603554), [OMIM:601457](http://purl.obolibrary.org/obo/OMIM_601457), [OMIM:241600](http://purl.obolibrary.org/obo/OMIM_241600), [OMIM:300400](http://purl.obolibrary.org/obo/OMIM_300400), [OMIM:600802](http://purl.obolibrary.org/obo/OMIM_600802), [Orphanet:33355](http://www.orpha.net/ORDO/Orphanet_33355), [Orphanet:169154](http://www.orpha.net/ORDO/Orphanet_169154), [Orphanet:35078](http://www.orpha.net/ORDO/Orphanet_35078), [Orphanet:169157](http://www.orpha.net/ORDO/Orphanet_169157), [Orphanet:276](http://www.orpha.net/ORDO/Orphanet_276), [OMIM:242880](http://purl.obolibrary.org/obo/OMIM_242880), [Orphanet:572](http://www.orpha.net/ORDO/Orphanet_572), [Orphanet:275](http://www.orpha.net/ORDO/Orphanet_275), [Orphanet:277](http://www.orpha.net/ORDO/Orphanet_277), [Orphanet:169160](http://www.orpha.net/ORDO/Orphanet_169160), [OMIM:267500](http://purl.obolibrary.org/obo/OMIM_267500), [OMIM:601705](http://purl.obolibrary.org/obo/OMIM_601705), [OMIM:610163](http://purl.obolibrary.org/obo/OMIM_610163), [Orphanet:331206](http://www.orpha.net/ORDO/Orphanet_331206), [OMIM:209920](http://purl.obolibrary.org/obo/OMIM_209920), [OMIM:102700](http://purl.obolibrary.org/obo/OMIM_102700), [OMIM:615617](http://purl.obolibrary.org/obo/OMIM_615617), [OMIM:604571](http://purl.obolibrary.org/obo/OMIM_604571), [OMIM:615615](http://purl.obolibrary.org/obo/OMIM_615615), [OMIM:608971](http://purl.obolibrary.org/obo/OMIM_608971), [Orphanet:39041](http://www.orpha.net/ORDO/Orphanet_39041), [Orphanet:34592](http://www.orpha.net/ORDO/Orphanet_34592), [OMIM:602450](http://purl.obolibrary.org/obo/OMIM_602450), 

**Class expressions from DL-Learner:**

- [HP:0004430](http://purl.obolibrary.org/obo/HP_0004430) (Severe combined immunodeficiency) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) 58.51%
- [HP:0004430](http://purl.obolibrary.org/obo/HP_0004430) (Severe combined immunodeficiency) and [HP:0011458](http://purl.obolibrary.org/obo/HP_0011458) (Abdominal symptom) 58.51%
- [HP:0002014](http://purl.obolibrary.org/obo/HP_0002014) (Diarrhea) and [HP:0004430](http://purl.obolibrary.org/obo/HP_0004430) (Severe combined immunodeficiency) 58.51%
- [HP:0004430](http://purl.obolibrary.org/obo/HP_0004430) (Severe combined immunodeficiency) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) 58.51%
- [HP:0004430](http://purl.obolibrary.org/obo/HP_0004430) (Severe combined immunodeficiency) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) 58.51%
- [HP:0004430](http://purl.obolibrary.org/obo/HP_0004430) (Severe combined immunodeficiency) and [HP:0011458](http://purl.obolibrary.org/obo/HP_0011458) (Abdominal symptom) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) 58.51%
- [HP:0004430](http://purl.obolibrary.org/obo/HP_0004430) (Severe combined immunodeficiency) and [HP:0011458](http://purl.obolibrary.org/obo/HP_0011458) (Abdominal symptom) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) 58.51%
- [HP:0002014](http://purl.obolibrary.org/obo/HP_0002014) (Diarrhea) and [HP:0004430](http://purl.obolibrary.org/obo/HP_0004430) (Severe combined immunodeficiency) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) 58.51%
- [HP:0002014](http://purl.obolibrary.org/obo/HP_0002014) (Diarrhea) and [HP:0004430](http://purl.obolibrary.org/obo/HP_0004430) (Severe combined immunodeficiency) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) 58.51%
- [HP:0004430](http://purl.obolibrary.org/obo/HP_0004430) (Severe combined immunodeficiency) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 56.43%
- [HP:0004430](http://purl.obolibrary.org/obo/HP_0004430) (Severe combined immunodeficiency) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 56.43%
- [HP:0004430](http://purl.obolibrary.org/obo/HP_0004430) (Severe combined immunodeficiency) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) 54.62%
- [HP:0004430](http://purl.obolibrary.org/obo/HP_0004430) (Severe combined immunodeficiency) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) 54.62%
- [HP:0004430](http://purl.obolibrary.org/obo/HP_0004430) (Severe combined immunodeficiency) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 51.59%
- [HP:0004430](http://purl.obolibrary.org/obo/HP_0004430) (Severe combined immunodeficiency) 48.09%


